ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

VYNE VYNE Therapeutics Inc

2.54
-0.01 (-0.39%)
Jun 01 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 178k126k167k6k99k135k114k76k
Operating Income -8.69M-8.29M-9.33M-7.98M-5.88M-10.32M-6.23M-6.83M
Pre Tax Income -8.69M-8.24M-9.26M-7.75M-5.61M-10.04M-6.07M-6.15M
Net Income 4.67M-8.48M-9.46M-9.95M-5.62M-10.06M-6.58M-6.19M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -8.69M-8.24M-9.26M-7.75M-5.61M-10.04M-6.07M-6.15M
EBITDA -8.65M-8.28M-9.16M-8.14M-5.88M-10.32M-6.23M-6.83M
Year End December 30 2023 20162017201820192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 674k4.58M10.64M020.99M14.76M477k424k
Operating Income -14.33M-29.59M-54.54M-76.24M-198.2M-68.03M-34.3M-29.26M
Pre Tax Income -14.07M-29.08M-51.45M-73.7M-255.83M-73.78M-33.93M-27.87M
Net Income -14.07M-29.08M-51.45M-73.7M-255.83M-73.33M-23.21M-28.45M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) -2.664-5.487-2.214-3.02-5.921-1.369-7.186-2.039
EBIT -14.33M-29.59M-54.54M-76.24M-197.09M-68.17M-33.93M-27.87M
EBITDA -14.33M-29.59M-54.51M-76.19M-197.86M-67.93M-34.22M-29.26M